203 related articles for article (PubMed ID: 28178678)
1. The awakening of the CDK10/Cyclin M protein kinase.
Guen VJ; Gamble C; Lees JA; Colas P
Oncotarget; 2017 Jul; 8(30):50174-50186. PubMed ID: 28178678
[TBL] [Abstract][Full Text] [Related]
2. STAR syndrome-associated CDK10/Cyclin M regulates actin network architecture and ciliogenesis.
Guen VJ; Gamble C; Perez DE; Bourassa S; Zappel H; Gärtner J; Lees JA; Colas P
Cell Cycle; 2016; 15(5):678-88. PubMed ID: 27104747
[TBL] [Abstract][Full Text] [Related]
3. CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome.
Guen VJ; Gamble C; Flajolet M; Unger S; Thollet A; Ferandin Y; Superti-Furga A; Cohen PA; Meijer L; Colas P
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19525-30. PubMed ID: 24218572
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders.
Robert T; Dock-Bregeon AC; Colas P
Mol Genet Genomic Med; 2021 Oct; 9(10):e1782. PubMed ID: 34369103
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of the human Cdk10/Cyclin Q complex.
Düster R; Ji Y; Pan KT; Urlaub H; Geyer M
Open Biol; 2022 Mar; 12(3):210381. PubMed ID: 35291876
[TBL] [Abstract][Full Text] [Related]
6. Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle.
Bagella L; Giacinti C; Simone C; Giordano A
J Cell Biochem; 2006 Oct; 99(3):978-85. PubMed ID: 16741970
[TBL] [Abstract][Full Text] [Related]
7. CDK10 Mutations in Humans and Mice Cause Severe Growth Retardation, Spine Malformations, and Developmental Delays.
Windpassinger C; Piard J; Bonnard C; Alfadhel M; Lim S; Bisteau X; Blouin S; Ali NB; Ng AYJ; Lu H; Tohari S; Talib SZA; van Hul N; Caldez MJ; Van Maldergem L; Yigit G; Kayserili H; Youssef SA; Coppola V; de Bruin A; Tessarollo L; Choi H; Rupp V; Roetzer K; Roschger P; Klaushofer K; Altmüller J; Roy S; Venkatesh B; Ganger R; Grill F; Ben Chehida F; Wollnik B; Altunoglu U; Al Kaissi A; Reversade B; Kaldis P
Am J Hum Genet; 2017 Sep; 101(3):391-403. PubMed ID: 28886341
[TBL] [Abstract][Full Text] [Related]
8. Development of a CDK10/CycM
Robert T; Johnson JL; Guichaoua R; Yaron TM; Bach S; Cantley LC; Colas P
Front Chem; 2020; 8():147. PubMed ID: 32175313
[TBL] [Abstract][Full Text] [Related]
9. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of cyclin-dependent kinase 10 (cdk10) gene impairs neural progenitor survival via modulation of raf1a gene expression.
Yeh CW; Kao SH; Cheng YC; Hsu LS
J Biol Chem; 2013 Sep; 288(39):27927-39. PubMed ID: 23902762
[TBL] [Abstract][Full Text] [Related]
11. A homozygous deleterious CDK10 mutation in a patient with agenesis of corpus callosum, retinopathy, and deafness.
Guen VJ; Edvardson S; Fraenkel ND; Fattal-Valevski A; Jalas C; Anteby I; Shaag A; Dor T; Gillis D; Kerem E; Lees JA; Colas P; Elpeleg O
Am J Med Genet A; 2018 Jan; 176(1):92-98. PubMed ID: 29130579
[TBL] [Abstract][Full Text] [Related]
12. Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity.
Kasten M; Giordano A
Oncogene; 2001 Apr; 20(15):1832-8. PubMed ID: 11313931
[TBL] [Abstract][Full Text] [Related]
13. CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loop.
Zhang X; Zhao Y; Yiminniyaze R; Zhu N; Zhang Y; Wumaier G; Xia J; Dong L; Zhou D; Wang J; Li C; Zhang Y; Li S
Mol Carcinog; 2024 Jan; 63(1):61-74. PubMed ID: 37737453
[TBL] [Abstract][Full Text] [Related]
14. CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells.
Yu JH; Zhong XY; Zhang WG; Wang ZD; Dong Q; Tai S; Li H; Cui YF
Oncol Rep; 2012 Apr; 27(4):1266-76. PubMed ID: 22209942
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
Roskoski R
Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
[TBL] [Abstract][Full Text] [Related]
16. In a nongenomic action, steroid hormone 20-hydroxyecdysone induces phosphorylation of cyclin-dependent kinase 10 to promote gene transcription.
Liu W; Cai MJ; Wang JX; Zhao XF
Endocrinology; 2014 May; 155(5):1738-50. PubMed ID: 24517229
[TBL] [Abstract][Full Text] [Related]
17. CDK10 is not a target for aberrant DNA methylation in breast cancer.
Heller G; Ziegler B; Brandstetter A; Novak S; Rudas M; Hennig G; Gehrmann M; Acht T; Zöchbauer-Müller S; Filipits M
Anticancer Res; 2009 Oct; 29(10):3939-44. PubMed ID: 19846932
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biological significance of Cdk10 in hepatocellular carcinoma.
Zhong XY; Xu XX; Yu JH; Jiang GX; Yu Y; Tai S; Wang ZD; Cui YF
Gene; 2012 Apr; 498(1):68-74. PubMed ID: 22326270
[TBL] [Abstract][Full Text] [Related]
19. CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene.
Bazzi ZA; Tai IT
Front Oncol; 2021; 11():655479. PubMed ID: 34277407
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the Kinase Domain of CDK10 Prevents Tumor Growth in a Preclinical Model of Colorectal Cancer, and Is Accompanied by Downregulation of Bcl-2.
Weiswald LB; Hasan MR; Wong JCT; Pasiliao CC; Rahman M; Ren J; Yin Y; Gusscott S; Vacher S; Weng AP; Kennecke HF; Bièche I; Schaeffer DF; Yapp DT; Tai IT
Mol Cancer Ther; 2017 Oct; 16(10):2292-2303. PubMed ID: 28663269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
